FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access.

FREE PREVIEW. Purchase online access to read the full version of this article.

Am Fam Physician. 2004 Nov 1;70(9):1648.

The Letter to the Editor, “Tolerance and Dependence Risk with the Use of Carisoprodol,” by Craig Heacock, M.D., and Mark S. Bauer, M.D. (April 1, 2004, page 1622), incorrectly stated that meprobamate is a schedule IV barbiturate with a long history of abuse. The second sentence in the first paragraph of the letter should have stated that meprobamate is a schedule IV drug that has a long history of abuse and exhibits cross-tolerance to barbiturates. Meprobamate is a bis-carbamate ester and is not a member of the barbiturate family. The online version of this letter has been corrected.


Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions

Information From Industry

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article